D.A. Davidson & Co’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

D.A. Davidson & Co’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-5,000	Closed	-$24K	–	2616
2016 Q4	$24K	Hold	5,000	–	–	﹤0.01%	1879
2016 Q3	$24K	Hold	5,000	–	–	﹤0.01%	1806
2016 Q2	$25K	Hold	5,000	–	–	﹤0.01%	1690
2016 Q1	$28K	Hold	5,000	–	–	﹤0.01%	1612
2015 Q4	$51K	Buy	+5,000	New	+$67.9K	﹤0.01%	1394

Other funds holding OSIR

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

FIM

Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

D.A. Davidson & Co's OSIR Position: Q1 2017 in Review

D.A. Davidson & Co sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 5,000 shares — an estimated $24K sold.

D.A. Davidson & Co first reported a position in OSIR in Q4 2015 and held it in 5 quarters. The position peaked at $51K in Q4 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

D.A. Davidson & Co reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
D.A. Davidson & Co sold 5,000 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $24K.
D.A. Davidson & Co first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2015 and held it in 5 quarters.
D.A. Davidson & Co's Osiris Therapeutics, Inc. Common Stock position peaked at $51K in Q4 2015.
11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on D.A. Davidson & Co's 13F filing for Q1 2017, filed 12 May 2017.